Akebia Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $4.0M | 2.9M | 1.39 |
| 2025-03-31 | $584k | 306k | 1.91 |
| 2024-12-31 | $452k | 237k | 1.91 |
| 2024-09-30 | $200k | 151k | 1.32 |
| 2024-06-30 | $48k | 47k | 1.02 |
| 2024-03-31 | $344k | 188k | 1.83 |
| 2023-12-31 | $379k | 306k | 1.24 |
| 2023-09-30 | $174k | 153k | 1.14 |
| 2023-03-31 | $26 | 49 | 0.55 |
| 2022-12-31 | $418 | 726 | 0.58 |
| 2022-09-30 | $15k | 47k | 0.32 |
| 2021-12-31 | $2.1M | 926k | 2.26 |
| 2021-03-31 | $3.8M | 1.1M | 3.38 |
| 2020-12-31 | $123k | 44k | 2.81 |
| 2020-09-30 | $39k | 16k | 2.52 |
| 2020-06-30 | $8.3M | 608k | 13.58 |
| 2020-03-31 | $746k | 98k | 7.60 |
| 2019-12-31 | $466k | 74k | 6.31 |
| 2019-09-30 | $1.3M | 330k | 3.92 |
| 2019-06-30 | $1.7M | 349k | 4.84 |
| 2019-03-31 | $457k | 56k | 8.18 |
| 2018-12-31 | $1.8M | 316k | 5.54 |
| 2018-09-30 | $455k | 52k | 8.83 |
| 2018-06-30 | $443k | 45k | 9.97 |
| 2018-03-31 | $342k | 36k | 9.54 |
| 2017-12-31 | $629k | 42k | 14.87 |
| 2017-09-30 | $537k | 27k | 19.68 |
| 2017-06-30 | $57k | 4.0k | 14.32 |
| 2017-03-31 | $3.0k | 322 | 9.32 |
| 2016-12-31 | $94k | 9.1k | 10.37 |
| 2016-09-30 | $0 | 25 | 0.00 |
| 2016-06-30 | $61k | 8.1k | 7.51 |
| 2015-12-31 | $121k | 9.4k | 12.93 |
| 2015-09-30 | $5.3k | 710 | 7.46 |
| 2015-06-30 | $42k | 4.0k | 10.42 |
| 2014-09-30 | $6.2k | 282 | 21.98 |